Defining the optimal sequence for the systemic treatment of metastatic breast cancer

Metastatic breast cancer is a heterogeneous disease that presents in varying forms, and a growing number of therapeutic options makes it difficult to determine the best choice in each particular situation. When selecting a systemic treatment, it is important to consider the medication administered i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mestres, J. A., iMolins, A. B., Martínez, L. C., López-Muñiz, J. I. C., Gil, E. C., de Juan Ferré, A., del Barco Berrón, S., Pérez, Y. F., Mata, J. G., Palomo, A. G., Gregori, J. G., Pardo, P. G., Mañas, J. J. I., Hernández, A. L., de Dueñas, E. M., Jáñez, N. M., Murillo, S. M., Bofill, J. S., Auñón, P. Z., Sanchez-Rovira, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239809/
https://www.ncbi.nlm.nih.gov/pubmed/27314861
http://dx.doi.org/10.1007/s12094-016-1520-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239809/
https://www.ncbi.nlm.nih.gov/pubmed/27314861
http://dx.doi.org/10.1007/s12094-016-1520-2

Ejemplares similares